On Friday 25 October at 14.00, Tua Gyldenholm defends her PhD dissertation entitled "Coagulation and thromboprophylaxis in oesophageal cancer patients undergoing surgery".

Venous blood clots is the most common potentially preventable cause of death in cancer patients undergoing surgery. To prevent blood clots, all patients receive blood-thinning medication during their hospital stay following cancer surgery. This PhD project investigates patients undergoing surgery for oesophageal cancer with the aim of determining whether extended preventive treatment with blood-thinning medication can further reduce the risk of blood clots after surgery. Furthermore, the project incvestigates if a blood sample taken before surgery may help predict which patients are at increased risk of developing blood clots.

The summary is written by the PhD student. 

The defence is public and takes place at Hjertesygdomme Konferencelokale, Entrance F, Level 2 (ground floor), Aarhus University Hospital. Please see the press release for more information. 

Contact

PhD student Tua Gyldenholm
Mail: tuagyl@clin.au.dk 
Phone: (+45) 25136781

Read full press release